VMware Inc. (VMW) Financials Nov 20, 2014, 4:35
VMware Inc. (VMW) Financials Nov 20, 2014, 4:35 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for VMware Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 2.02B 2.86B 3.77B 4.61B 5.15B
Cost of Goods Sold (COGS) incl. D&A 359.73M 493.72M 621.99M 721.32M 730M
COGS excluding D&A 161.24M 233.16M 306.12M 366.46M 393M
Depreciation & Amortization Expense 198.49M 260.55M 315.87M 354.87M 337M
Depreciation 102.3M 114.2M 126.3M 130.9M 141M
Amortization of Intangibles 96.19M 146.35M 189.57M 223.97M 196M
Gross Income 1.66B 2.36B 3.15B 3.88B 4.42B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.44B 1.94B 2.41B 3.01B 3.32B
Research & Development 496.55M 652.97M 775.05M 999.21M 1.08B
Other SG&A 948.36M 1.28B 1.63B 2.01B 2.23B
Other Operating Expense 0 0 0 0 0
Unusual Expense 7.2M 23.9M 0 3.8M 26M
EBIT after Unusual Expense (7.2M) (23.9M) 0 (3.8M) (26M)
Non Operating Income/Expense 9.62M 9.72M 46.99M (732,000) 41M
Non-Operating Interest Income 8.23M 6.63M 16.16M 26.56M 30M
Equity in Affiliates (Pretax) - - - - 0
Interest Expense 6.5M 4.07M 3.91M 4.65M 4M
Gross Interest Expense 6.5M 4.07M 3.91M 4.65M 4M
Interest Capitalized 0 0 0 0 0
Pretax Income 223.45M 416.38M 794.41M 893.11M 1.15B
Income Tax 26.35M 58.94M 70.48M 147.41M 133M
Income Tax - Current Domestic 47.18M 81.29M 43.49M 174.52M 3M
Income Tax - Current Foreign 19.64M 34.59M 41.35M 44.04M 72M
Income Tax - Deferred Domestic (39.54M) (51.21M) (12.21M) (78.5M) 63M
Income Tax - Deferred Foreign (938,000) (5.74M) (2.15M) 7.35M (5M)
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 197.1M 357.44M 723.94M 745.7M 1.01B
Minority Interest Expense 0 0 0 0 0
Net Income 197.1M 357.44M 723.94M 745.7M 1.01B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 197.1M 357.44M 723.94M 745.7M 1.01B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 197.1M 357.44M 723.94M 745.7M 1.01B
EPS (Basic) 0.50 0.87 1.72 1.75 2.36
Basic Shares Outstanding 394.27M 409.81M 421.19M 426.66M 429.09M
EPS (Diluted) 0.49 0.84 1.68 1.72 2.34
Diluted Shares Outstanding 399.78M 423.45M 431.75M 433.97M 433.42M
EBITDA 417.78M 688.54M 1.05B 1.23B 1.44B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
From Kitchen Experiment to U.S. Debut Here's a story that barely fits the tight mold of your typical business textbook. Hair Syrup, born from the brain of a university student tinkering at her kitchen table, is about to make waves across the pond. Lucie Macleod did what many dream of—she took a DIY hair oil project and spun it into a multimillion-dollar brand, now set...
Continue Reading
Unpacking Cove Capital's Latest Victory Cove Capital Investments has pulled off another coup, raising a hefty $9,964,510 for its Cove Essential Net Lease Industrial 108 DST. It's a Regulation D, Rule 506(c) offering, now fully subscribed, spotlighting a debt-free investment ethos and a rock-solid logistics site in Anchorage, Alaska. Strategic Facility Anchoring Investment...
Continue Reading
Shareholder Concerns Rise Amid Corporate Buyouts The stakes are high for the shareholders of Distribution Solutions Group, Eagle Financial Services, Safety Insurance Group, and Utz Brands as their companies face potential buyouts. Let's chew over what's on the table: the sweet deals insiders might score and the legal maneuvers in play. Halper Sadeh LLC, a heavy-hitting...
Continue Reading
Unveiling the RARE Foundation's New Identity In the stock market, you ride waves of change, and let me tell you, it ain't just stocks and bonds that change names and faces. Case in point: The EveryLife Foundation for Rare Diseases has spiffed up as the RARE Foundation. New name, new logo, the whole enchilada. This isn't just a cosmetic touch-up, though. It's about...
Continue Reading
Eagle Financial Services Under the Microscope A buzz is picking up in the world of mergers and acquisitions, and this time, it's Eagle Financial Services, Inc. (NASDAQ: EFSI) caught in the crosshairs. What's the chatter all about? Well, it looks like Juan Monteverde and his crew over at Monteverde & Associates PC have set their sights on Eagle's proposed sale to John...
Continue Reading
Pioneering Efforts Across Decades Here’s an effort that bucks the usual corporate talk. Aflac, the supplemental insurance giant, isn’t just mumbling about its mission; it's doing the heavy lifting in the fight against childhood cancer and blood disorders. With over $200 million in contributions poured into the cause over more than 30 years, they're putting the capital...
Continue Reading
Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...
Continue Reading
The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...
Continue Reading
Pocketing Insider Gains Amidst Shareholder Concerns Let me tell you, it smells like another day in the financial jungle where insiders might be feasting while the regular Joe shareholders are left nibbling on crumbs. Fulcrum Therapeutics, Weave Communications, and Bio-Techne are in the crosshairs for deals that may favor those on the inside track over you and me, the...
Continue Reading
A Community-Driven Retail Innovation The grocery game just got a little more personal in Michigan, and we're not talking about run-of-the-mill retail pitches. Fresh Thyme Market, known for its commitment to local and natural products, is shaking things up with their Pitch Thyme Competition. This ain’t your usual product presentation. It’s a whole new ball game where...
Continue Reading
Top 5 Most Recently Viewed Articles
Sofwave Medical's Strategic Participation in the Upcoming MedTech Summit Sofwave Medical Ltd, a leading innovator in non-invasive aesthetic medical devices, has announced its participation in an exciting virtual event. The Jefferies Private MedTech Summit serves as a platform for companies to showcase their latest innovations and connect with investors. This summit will...
Continue Reading
New Leadership Signals Growth for Defense Metals Corp. Defense Metals Corp. is embarking on a new chapter with significant changes in leadership that aim to enhance its operational capabilities and strategic direction. The appointment of Mr. Mark Tory as President and Chief Executive Officer marks a pivotal moment for the Company. He takes over from Dr. Luisa Moreno, who...
Continue Reading
Dream Pairs Achieves Landmark Victory in Trademark Litigation Dream Pairs, a prominent footwear brand under Miracle Miles Group Inc., successfully navigated a high-profile trademark dispute in the United Kingdom. This case involved allegations that Dream Pairs' distinctive logo, used on its football boots, infringed upon Iconix's "double diamond" trademarks. The decision...
Continue Reading
U.S. Customs to Auction Seized Aluminum In a significant move, U.S. Customs has announced an upcoming auction of 22,000 tons of seized aluminum. This auction is poised to attract attention from various industries that utilize aluminum for numerous applications, presenting a unique opportunity for both small and large enterprises. Understanding the Aluminum Market The...
Continue Reading
Monopar Therapeutics Launches New Stock Offerings Monopar Therapeutics Inc. (NASDAQ: MNPR), a clinical-stage biopharmaceutical company, is making headlines with its substantial progress. The company has recently announced the pricing for a new stock offering, alongside a concurrent private placement of pre-funded warrants. Over the past year, Monopar's stock has seen an...
Continue Reading